James V Tricoli

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer
    James V Tricoli
    Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, 6130 Executive Blvd, Executive Plaza North, Rockville, MD 20852, USA
    J Natl Cancer Inst 103:628-35. 2011
  2. ncbi MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis
    James V Tricoli
    Diagnostic Biomarkers and Technology Branch, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland 20852, USA
    Cancer Res 67:4553-5. 2007
  3. ncbi Detection of prostate cancer and predicting progression: current and future diagnostic markers
    James V Tricoli
    Diagnostics Research Branch, Cancer Diagnosis Program, National Cancer Institute, Rockville, Maryland, USA
    Clin Cancer Res 10:3943-53. 2004

Collaborators

Detail Information

Publications3

  1. ncbi Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer
    James V Tricoli
    Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, 6130 Executive Blvd, Executive Plaza North, Rockville, MD 20852, USA
    J Natl Cancer Inst 103:628-35. 2011
    ....
  2. ncbi MicroRNA: Potential for Cancer Detection, Diagnosis, and Prognosis
    James V Tricoli
    Diagnostic Biomarkers and Technology Branch, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland 20852, USA
    Cancer Res 67:4553-5. 2007
  3. ncbi Detection of prostate cancer and predicting progression: current and future diagnostic markers
    James V Tricoli
    Diagnostics Research Branch, Cancer Diagnosis Program, National Cancer Institute, Rockville, Maryland, USA
    Clin Cancer Res 10:3943-53. 2004
    ..Finally, we discuss how to conduct evaluations of candidate prostate cancer markers and some of the issues involved in the validation process...